Alkem Laboratories
Alkem Laboratories is an Indian pharmaceutical company that specializes in the development, manufacture, and sale of a wide range of pharmaceutical products, including branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals. The company focuses on both acute and chronic therapeutic areas, offering products for conditions such as infections, pain management, cardiovascular issues, diabetes, gynecology, neurology, dermatology, and osteoporosis. Alkem has established a significant presence in the Indian market and also exports its products to countries including the United States, Australia, and the United Kingdom. With over a decade among the top ten pharmaceutical companies in India, Alkem Laboratories continues to expand its reach and product offerings in both domestic and international markets.
4 past transactions
Adroit Biomed
Acquisition in 2025
Adroit Biomed specializes in dermato-cosmetology and offers excellent quality medicines that drive meaningful change in dermatology.
Enzene Biosciences
Venture Round in 2023
Enzene Biosciences is a biotechnology company focused on providing affordable medicines through the development of biosimilars. The company employs advanced technologies, analytics, and a state-of-the-art manufacturing facility to enhance the efficiency of its operations. Enzene specializes in cloning, process development, and novel formulation development, which enables clients to leverage innovative solutions in commercial microbial manufacturing. By fostering strategic global alliances, Enzene aims to broaden the reach of its disruptive technologies and improve healthcare outcomes worldwide. The company is recognized for its strong workplace culture, making it an attractive employer in the biotech sector.
Eyestem
Series A in 2022
Eyestem is a cell therapy company focused on developing scalable therapies to treat incurable diseases, with a particular emphasis on conditions such as age-related macular degeneration (Dry AMD). Founded by a team of experts in clinical trials, cell therapy, and ophthalmology, the company is supported by a distinguished advisory board and has established collaborations with leaders in the field. Eyestem aims to create a global and accessible cell therapy platform that ensures consistent quality and efficacy in its products, ultimately democratizing access to advanced treatment technologies for patients worldwide. Over the coming years, the company will concentrate on refining its platform to enhance safety and effectiveness in its therapeutic offerings.
Zapkey
Seed Round in 2022
Zapkey is a real estate technology company that offers a platform designed to streamline the buying and selling of properties. It guarantees home sales within three months of the listing date, ensuring that if a property does not sell within this timeframe, Zapkey will purchase it directly. The platform utilizes data algorithms to determine fair market prices, promoting transparency and fairness in property transactions. By providing these services, Zapkey aims to simplify the real estate process for its customers and enhance their confidence in property sales.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.